top of page

SAMHSA TO ISSUE INTERIM MEASURES IF BUPRENORPHINE RULE DELAYED

SAMHSA (2/10) -- HHS has says that if the SAMHSA is unable to complete rulemaking that allows providers in opioid treatment programs to continue to initiate buprenorphine following a telehealth visit before the May 11 end of the public health emergency, SAMHSA will enact interim measures to bridge any gap that may result after the PHE ends. Cont.

8 views0 comments

Recent Posts

See All

Comments


bottom of page